Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.
PET holds promise for carotid plaque assessments
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
New-onset AFib is common after CABG—but typically not persistent or symptomatic
The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.
Hospital in Mexico earns first heart failure certification of its kind
A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.
Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM
No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

Unknowingly infected individuals may be spreading COVID as widely as those who’ve tested positive

CDC researchers are estimating that asymptomatic COVID-19 carriers account for at least half of all community transmissions. This includes carriers who never develop symptoms as well as those who later do.

Heart damage less common among athletes who recover from COVID-19 than previously believed, cardiologists find

“The differences in the findings are extremely important,” one researcher said.

Colchicine use proven beneficial for patients with coronary artery disease, according to new meta-analysis

Researchers explored data from more than 11,000 patients.

New technique for battling blood clots uses nanodroplets, ultrasound imaging

The new treatment strategy shows significant potential. A full evaluation was published in Microsystems & Nanoengineering.

Same-day discharge after PCI? American College of Cardiology shares a new guidance

Knowing when same-day discharge is the right choice—and when it isn’t—can be especially challenging for cardiologists and their care teams.

FDA announces new recall for extended-release metformin due to contamination

Numerous recalls for ER metformin occurred in 2020. This is the first of 2021.

Why heart failure patients should receive a COVID-19 vaccine as quickly as possible

New research, published in ESC Heart Failure, details why heart failure patients are a high-risk group and will benefit from vaccination.

Dr. Makary: ‘Just because you can get the vaccine doesn’t mean you should’

Among the many Americans refusing to get vaccinated against COVID-19 when their turn comes up is a prominent surgeon who’s also a professional medical communicator and a Johns Hopkins public-health professor.

Clinical

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

PET holds promise for carotid plaque assessments

New-onset AFib is common after CABG—but typically not persistent or symptomatic

Hospital in Mexico earns first heart failure certification of its kind

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM